News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,181 Results
Type
Article (46614)
Company Profile (337)
Press Release (674230)
Multimedia
Podcasts (65)
Webinars (12)
Section
Business (208924)
Career Advice (2052)
Deals (35938)
Drug Delivery (108)
Drug Development (82988)
Employer Resources (176)
FDA (16581)
Job Trends (15363)
News (353294)
Policy (33725)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2761)
Academic (1)
Accelerated approval (5)
Adcomms (23)
Allergies (87)
Alliances (50951)
ALS (91)
Alzheimer's disease (1416)
Antibody-drug conjugate (ADC) (129)
Approvals (16580)
Artificial intelligence (268)
Autoimmune disease (23)
Automation (16)
Bankruptcy (362)
Best Places to Work (12078)
BIOSECURE Act (22)
Biosimilars (109)
Biotechnology (239)
Bladder cancer (79)
Brain cancer (28)
Breast cancer (285)
Cancer (2298)
Cardiovascular disease (183)
Career advice (1716)
Career pathing (31)
CAR-T (154)
Cell therapy (435)
Cervical cancer (19)
Clinical research (67355)
Collaboration (865)
Compensation (537)
Complete response letters (22)
COVID-19 (2683)
CRISPR (45)
C-suite (251)
Cystic fibrosis (106)
Data (2210)
Decentralized trials (2)
Denatured (26)
Depression (45)
Diabetes (283)
Diagnostics (6517)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (128)
Drug pricing (112)
Drug shortages (27)
Duchenne muscular dystrophy (94)
Earnings (87490)
Editorial (40)
Employer branding (21)
Employer resources (150)
Events (115684)
Executive appointments (736)
FDA (17849)
Featured Employer (55)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (776)
Gene editing (113)
Generative AI (25)
Gene therapy (327)
GLP-1 (764)
Government (4583)
Grass and pollen (5)
Guidances (54)
Healthcare (19582)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (122)
Indications (30)
Infectious disease (2831)
Inflammatory bowel disease (142)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (98)
Interviews (316)
IPO (16681)
IRA (42)
Job creations (3740)
Job search strategy (1460)
Kidney cancer (10)
Labor market (38)
Layoffs (482)
Leadership (17)
Legal (8196)
Liver cancer (78)
Lung cancer (324)
Lymphoma (154)
Machine learning (7)
Management (59)
Manufacturing (316)
MASH (69)
Medical device (13568)
Medtech (13573)
Mergers & acquisitions (19802)
Metabolic disorders (721)
Multiple sclerosis (80)
NASH (18)
Neurodegenerative disease (98)
Neuropsychiatric disorders (29)
Neuroscience (1968)
NextGen: Class of 2025 (6789)
Non-profit (4806)
Northern California (2678)
Now hiring (39)
Obesity (391)
Opinion (219)
Ovarian cancer (76)
Pain (88)
Pancreatic cancer (85)
Parkinson's disease (152)
Partnered (21)
Patents (236)
Patient recruitment (110)
Peanut (48)
People (59059)
Pharmaceutical (77)
Pharmacy benefit managers (20)
Phase I (20981)
Phase II (29536)
Phase III (22126)
Pipeline (1187)
Policy (147)
Postmarket research (2746)
Preclinical (9014)
Press Release (67)
Prostate cancer (109)
Psychedelics (30)
Radiopharmaceuticals (256)
Rare diseases (402)
Real estate (6095)
Recruiting (67)
Regulatory (23080)
Reports (46)
Research institute (2483)
Resumes & cover letters (353)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (69)
Series A (134)
Series B (88)
Service/supplier (12)
Sickle cell disease (57)
Southern California (2309)
Special edition (15)
Spinal muscular atrophy (154)
Sponsored (30)
Startups (3734)
State (2)
Stomach cancer (14)
Supply chain (72)
Tariffs (39)
The Weekly (37)
United States (23433)
Vaccines (712)
Venture capitalists (42)
Weight loss (260)
Women's health (36)
Worklife (15)
Date
Today (210)
Last 7 days (875)
Last 30 days (2748)
Last 365 days (33706)
2025 (10704)
2024 (36138)
2023 (40953)
2022 (52189)
2021 (56794)
2020 (55285)
2019 (48029)
2018 (36290)
2017 (33062)
2016 (32686)
2015 (38753)
2014 (32417)
2013 (27698)
2012 (29857)
2011 (30425)
2010 (28445)
Location
Africa (781)
Alabama (58)
Alaska (7)
Arizona (237)
Arkansas (13)
Asia (39518)
Australia (6513)
California (6161)
Canada (2020)
China (529)
Colorado (274)
Connecticut (283)
Delaware (147)
Europe (86237)
Florida (914)
Georgia (213)
Idaho (57)
Illinois (555)
India (26)
Indiana (314)
Iowa (11)
Japan (160)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (903)
Massachusetts (4674)
Michigan (218)
Minnesota (397)
Mississippi (2)
Missouri (84)
Montana (28)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1756)
New Mexico (29)
New York (1759)
North Carolina (1010)
North Dakota (9)
Northern California (2678)
Ohio (203)
Oklahoma (15)
Oregon (37)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (33)
South America (1137)
South Carolina (22)
South Dakota (1)
Southern California (2309)
Tennessee (102)
Texas (915)
Utah (184)
Virginia (151)
Washington D.C. (65)
Washington State (569)
West Virginia (3)
Wisconsin (55)
721,181 Results for "foundation medicine inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Foundation Medicine Launches RNA Sequencing Test, FoundationOne®RNA, in the U.S.
Foundation Medicine, Inc., announced the U.S. launch of FoundationOne®RNA, a tissue-based RNA sequencing test for the detection of cancer-related fusions across 318 genes.
May 21, 2024
·
7 min read
Press Releases
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease
January 8, 2025
·
5 min read
Press Releases
Foundation Medicine Collaborates with Sumitomo Pharma America to Advance Investigational Treatment for Patients with Acute Leukemia with NPM1 Mutations or KMT2A Rearrangements Using the FoundationOne®Heme Platform
February 19, 2025
·
4 min read
Business
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. announced a partnership to develop Foundation Medicine’s tissue-based comprehensive genomic profiling test, FoundationOne®CDx, as a companion diagnostic for PMV Pharma’s rezatapopt, a first-in-class, investigational therapy for patients with locally advanced or metastatic solid tumors that have a TP53 Y220C mutation.
May 29, 2024
·
5 min read
Genetown
Foundation Medicine Announces Details of Over 20 Presentations at the 2024 ASCO® Annual Meeting
Foundation Medicine, Inc., announced that 22 new pieces of research from its robust oncology diagnostics portfolio will be presented at the 2024 American Society of Clinical Oncology Annual Meeting from May 31 to June 4 in Chicago.
May 24, 2024
·
14 min read
Press Releases
AKAGERA Medicines, Inc. announces the completion of the first cohort in the IV AKG-100 phase 1 study for the treatment of pulmonary tuberculosis.
April 2, 2025
·
5 min read
Business
Qu Biologics and Foundation Medicine Collaborate to Impact the Care of Patients with Late-Stage Colorectal Cancer
Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators, a novel platform of immunotherapies designed to restore innate immune function, and Foundation Medicine, Inc. are pleased to announce a partnership aimed to impact the care of patients with late-stage colorectal cancer undergoing surgery.
June 6, 2024
·
4 min read
Press Releases
Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer
March 13, 2025
·
6 min read
Genetown
Foundation Medicine Announces Partnership with Repare Therapeutics to Provide Genomic Profiling Services to Support Clinical Trials and to Develop Companion Diagnostic for Lunresertib
Foundation Medicine, Inc., announced that it has formed a collaboration with Repare Therapeutics, a leading clinical-stage precision oncology company, to provide prospective genomic profiling to patients in Repare’s ongoing Phase I/Ib MYTHIC study of lunresertib alone or in combinations in genomically-defined patient populations.
June 12, 2024
·
3 min read
Business
Foundation Medicine Appoints Dan Malarek as Chief Executive Officer
Foundation Medicine, Inc., announced the appointment of Roche executive, Dan Malarek, as Chief Executive Officer.
December 14, 2023
·
1 min read
1 of 72,119
Next
